Cardiac AI Safety: Is Your Investment at 5.8% Recall Risk?
The promise of artificial intelligence in cardiology is immense, offering unprecedented opportunities for early detection, personalized treatment, and…
Unlocking Cardiac AI’s Trillion-Dollar Prevention Market
The way we practice cardiology is changing, and it’s not a slow drift. We’re moving from a defensive,…
Sword Health’s 4.0:1 ROI: A Deep Dive for Investors
The Sword Health Chapter: A 4.0:1 Chapter in MSK Digital Therapeutics Our ongoing narrative, which began by ranking…
AI’s Heartbeat: Investing in Preventive Cardiology’s Future
Preventive cardiology is changing, and fast. The reason is the arrival of foundational artificial intelligence (AI) layers that…
AI’s Billion-Dollar Impact: Halting Chronic Disease Escalation
Chronic diseases are a massive headache for modern healthcare because they’re often silent until significant damage is already…
Cardiac AI: Unpacking Long-Term Value for Investors
The real fight in cardiovascular care isn’t just the initial diagnosis, it’s getting patients to stick with complex…
AI in Cardiac Prevention: The Billion Dollar Paradigm Shift
Preventive cardiology is finally moving on from the static risk calculators we’ve all been using for years. We’re…
Hinge Health & the IPO: De-Risking Digital Health for Investors
The IPO Class of 2025 is poised to raise critical questions about the economics of healthcare AI, the…
Cardiac AI: Investing in Early Intervention’s Billion-Dollar Future
We’re all feeling the pressure from the rising tide of cardiovascular disease, and it’s forcing a hard look…
Vanta: De-Risking Cardiac AI Investment with Clinical Evidence
What does this new evidence mean for my practice raises critical questions about Evidence-Based Practice Translation investment durability…